KU Leuven-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2004

  1. Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: Integrated efficacy data and novel analyses from two large, randomised, phase III trials

    British Journal of Cancer, Vol. 90, Núm. 6, pp. 1190-1197

2002

  1. First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/leucovorin

    Annals of Oncology, Vol. 13, Núm. 4, pp. 566-575

2001

  1. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study

    Journal of Clinical Oncology, Vol. 19, Núm. 21, pp. 4097-4106

1996

  1. 'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia

    European Journal of Cancer Part A, Vol. 32, Núm. SUPPL. 5, pp. 1945-1954

  2. Final results of a randomised trial comparing 'Tomudex'® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer

    Annals of Oncology, Vol. 7, Núm. 9, pp. 961-965

1995

  1. 'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia

    European Journal of Cancer, Vol. 31, Núm. 12, pp. 1945-1954